Company Description
GCM Grosvenor Inc. is global alternative asset management solutions provider.
The firm primarily provides its services to pooled investment vehicles. It also provides its services to investment companies, high net worth individuals, pension and profit sharing plans and state or municipal government entities.
The firm invests in equity and alternative investment markets of the United States and internationally.
The firm invests in multi-strategy, credit-focused, equity-focused, macro-focused, commodity-focused, and other specialty portfolios.
It focuses in hedge fund asset classes, private equity, real estate, and/or infrastructure, credit and absolute return strategies.
It also focuses in primary fund investments, secondary fund investments, and co-investments with a focus on buyout, distressed debt, mezzanine, venture capital/growth equity investments.
The firm seeks to do seed investments in small, emerging, and diverse private equity firms. The firm seeks to make regionally-focused investments in middle-market buyout.
It prefers to invest in aerospace and defense, advanced electronics, information technology, biosciences, and advanced materials.
It focuses on Ohio and the Midwest region. The firm employs fundamental and quantitative analysis.
GCM Grosvenor Inc. was founded in 1971 and is based in Chicago, Illinois with additional offices in North America, Asia, Australia and Europe.
It operates as a subsidiary of Grosvenor Capital Management Holdings LLLP.
| Country | United States |
| Founded | 1971 |
| Industry | Asset Management |
| Sector | Financials |
| Employees | 549 |
| CEO | Michael Sacks |
Contact Details
Address: 900 North Michigan Avenue, Suite 1100 Chicago, Illinois 60611-6558 United States | |
| Phone | 312-506-6500 |
| Website | gcmgrosvenor.com |
Stock Details
| Ticker Symbol | GCMG |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001819796 |
| CUSIP Number | 36831E108 |
| ISIN Number | US36831E1082 |
| SIC Code | 6282 |
Key Executives
| Name | Position |
|---|---|
| Michael Jay Sacks J.D. | Board Chairman and Chief Executive Officer |
| Jonathan Reisin Levin | President and Director |
| Pamela Lyn Bentley CPA | Chief Financial Officer |
| Frederick Emmer Pollock J.D. | Chief Investment Officer and MD |
| Sandra Buchanan Hurse | Chief Human Resources Officer and MD |
| Kathleen Patricia Sullivan CPA | Chief Accounting Officer and MD of Finance in Chicago |
| Eric David Levin | Chief Technology Officer and MD, Office of the Chairman |
| Stacie Driebusch Selinger | Head of Investor Relations and MD, Office of the Chairman |
| Burke Johnson Montgomery J.D. | General Counsel and MD |
| David Bruce Small | Managing Director of Absolute Return Strategies |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 8, 2025 | SCHEDULE 13G/A | Filing |
| Aug 7, 2025 | 10-Q | Quarterly Report |
| Aug 7, 2025 | 8-K | Current Report |
| Aug 4, 2025 | SCHEDULE 13G/A | Filing |
| Jul 31, 2025 | SCHEDULE 13G | Filing |
| Jul 29, 2025 | 4 | Statement of changes in beneficial ownership of securities |
| Jul 17, 2025 | SCHEDULE 13G/A | Filing |
| Jul 16, 2025 | SCHEDULE 13G/A | Filing |
| Jul 14, 2025 | 8-K | Current Report |
| Jul 9, 2025 | EFFECT | Notice of Effectiveness |